Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice

Koehl, G. E. and Spitzner, M. and Ousingsawat, J. and Schreiber, R. and Geissler, E. K. and Kunzelmann, K. (2010) Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice. ONCOGENE, 29 (10). pp. 1553-1560. ISSN 0950-9232,

Full text not available from this repository. (Request a copy)

Abstract

The adenomatous polyposis coli (APC) gene is mutated in familial adenomatous polyposis. Mice with a heterozygous APC(Min) mutation develop multiple intestinal neoplasia (Min) leading to premature death. Early in colorectal carcinogenesis, APC(Min/+) mice show enhanced Akt-mammalian target of rapamycin (mTOR) signaling, which is paralleled by upregulation of oncogenic K+ channels. In this study, we tested the effect of mTOR inhibition with rapamycin on tumor formation in APC(Min/+) mice and evaluated ion channel regulation. We found that continuous long-term rapamycin treatment of APC(Min/+) mice dramatically inhibits intestinal neoplasia. Moreover, although untreated APC(Min/+) mice lose weight, experience intestinal bleeding and succumb to multiple neoplasia by 22.3 +/- 1.4 weeks of age, mice treated with rapamycin maintain stable weight and survive long term (39.6 +/- 3.4 weeks), with more than 30% surviving > 1 year. Impressively, abnormalities in colonic electrolyte transport typical for APC(Min/+) mice are abolished, along with the suppression of epithelial Na+ channel (ENaC) and oncogenic K+ ion channels BK, Elk1 and Erg1, both functionally and at mRNA levels. These results show that continuous prophylaxis by rapamycin markedly inhibits the development of APC mutation-related polyposis, and suggest a novel contributing mechanism of action through the blockade of intestinal oncogenic ion channels. Oncogene (2010) 29, 1553-1560; doi:10.1038/onc.2009.435; published online 7 December 2009

Item Type: Article
Uncontrolled Keywords: GATED POTASSIUM CHANNELS; K+ CHANNELS; ADENOMATOUS POLYPOSIS; COLORECTAL-CANCER; COLONIC-CARCINOMA; APC GENE; CELLS; PROLIFERATION; MTOR; COMBINATION; mTOR; familial adenomatous polyposis; ion channels; APCMin/ plus mice; rapamycin; Sirolimus
Subjects: 500 Science > 570 Life sciences
600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Biology, Preclinical Medicine > Institut für Physiologie > Prof. Dr. Karl Kunzelmann
Depositing User: Dr. Gernot Deinzer
Date Deposited: 06 Aug 2020 04:42
Last Modified: 06 Aug 2020 04:42
URI: https://pred.uni-regensburg.de/id/eprint/25118

Actions (login required)

View Item View Item